Log in to your Inderes Free account to see all free content on this page.
Aptahem
0.91 SEK
-2.56 %
Less than 1K followers
APTA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Aptahem
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 161.88 | 101.18 | 54.60 | 31.23 | 7.30 | 1.41 | 1.15 |
| Shares | 0.7 | 0.7 | 1.1 | 2.3 | 2.6 | 12.6 | 21.0 |
| Market cap | 114.0 | 68.0 | 57.4 | 70.4 | 18.6 | 17.8 | 24.0 |
| Enterprise value | 92.1 | 39.5 | 11.2 | 50.1 | 21.5 | 13.6 | 21.1 |
| EV/S | - | - | - | - | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| EV/EBIT | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 4.83 | 2.62 | 1.09 | 1.17 | 0.34 | 0.27 | 0.36 |
| P/S | - | - | - | - | - | - | - |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 91.9 % | 85.3 % | 95.9 % | 86.4 % | 85.7 % | 96.5 % | 98.3 % |
| Gearing ratio | - | - | - | - | 9.3 % | - | - |
Login required
This content is only available for logged in users